Reuters logo
BRIEF-Tigenix granted orphan drug designation from the U.S. FDA for CX601
2017年10月23日 / 凌晨5点13分 / 1 个月前

BRIEF-Tigenix granted orphan drug designation from the U.S. FDA for CX601

Oct 23 (Reuters) - Tigenix Nv

* Tigenix granted orphan drug designation from the U.S. FDA for cx601

* ‍exploring expedited pathways to accelerate submission and review process for U.S. Regulatory approval​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below